Combinational drug therapies
US11628176B2 · kind B2 · utility
1Cited by
89References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 20, 2021 |
| Grant date | Apr 18, 2023 |
| Priority date | — |
| Expiry date | Aug 20, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a method of treating a subject suffering from a cancer, comprising administering to the subject a combination of agents comprising:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.